The Forum, Boston Landing
Boston, MA
On April 23rd, Wilson Sonsini senior counsel Dan Orr will participate in the Boston-London Innovation Summit. As part of the panel “Navigating Regulatory Uncertainty & Investment Strategies,” Dan will discuss regulatory issues facing the United States in the life sciences field.
The Boston-London Innovation Summit explores this innovation corridor growth with special focus on life sciences, investment strategies, and the changing regulatory environment. The event brings together leaders from both cities to discuss new growth opportunities, cutting-edge research collaborations, and investment trends shaping the future of science and technology.
To RSVP, please access https://www.tickettailor.com/events/lendleaseeurope/1656804.
Hannah Hebertson
hhebertson@wsgr.com
Dan Orr is senior counsel at Wilson Sonsini Goodrich & Rosati, where he brings an insider’s perspective to helping clients prevent and solve problems with the U.S. Food & Drug Administration. Dan, a former FDA regulatory counsel, has more than 20 years of experience concerning regulation of drugs, biologics, and medical devices.